Development of cloning technology for the Australian Pig Industry. Cloning has the potential to be the most efficient of the reproductive technologies developed for increasing genetic improvement in livestock. Currently up to 5% of cloned embryos develop to term in the pig. This is higher than that reported for cattle and sheep. Moreover the use of this technology in the pig does not appear not to result in the same sorts of problems and losses seen around the time of birth in these species ....Development of cloning technology for the Australian Pig Industry. Cloning has the potential to be the most efficient of the reproductive technologies developed for increasing genetic improvement in livestock. Currently up to 5% of cloned embryos develop to term in the pig. This is higher than that reported for cattle and sheep. Moreover the use of this technology in the pig does not appear not to result in the same sorts of problems and losses seen around the time of birth in these species i.e. the majority of cloned pigs appear normal and are healthy at birth. However before cloning can be used commercially, current efficiencies need to be increased approx two fold for this to be economically viable. The aim of the present study is to improve the efficiency of our current cloning protocol and develop associated technologies such as embryo freezing to facilitate commercialisation. This will ensure that the Australian Pig Industry remains competitive at a pivotal time in its development.Read moreRead less
Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a c ....Development of a proto-type vaccine against gastrointestinal nematode larvae. Gastrointestinal parasites are the major cause of production losses in the Australian sheep and wool industries. Drug treatment is predominantly used to control infections but drug resistance has reached critical levels and is threatening the viability of sheep production in many rural areas. In collaboration with an international Animal Health company, we aim to develop vaccines against these parasites and provide a clean, non-toxic alternative to drug treatment. The groundbreaking research involved in this project will also keep Australian animal scientists at the forefront of vaccine research and increase their capacity to attract further support from Industry.Read moreRead less